Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa.

Lewis, Joseph; Iqbal, Omer; Jeske, Walter; Hoppensteadt, Debra; Siddiqui, Fakiha; Fareed, Jawed

Lewis, Joseph; Iqbal, Omer; Jeske, Walter; Hoppensteadt, Debra; Siddiqui, Fakiha; Fareed, Jawed.

Afiliação

Lewis J; Cardiovascular Research Institute, 550858Loyola University Chicago, Health Sciences Divisions, Maywood, IL, USA.
Iqbal O; Cardiovascular Research Institute, 550858Loyola University Chicago, Health Sciences Divisions, Maywood, IL, USA.
Jeske W; Cardiovascular Research Institute, 550858Loyola University Chicago, Health Sciences Divisions, Maywood, IL, USA.
Hoppensteadt D; Cardiovascular Research Institute, 550858Loyola University Chicago, Health Sciences Divisions, Maywood, IL, USA.
Siddiqui F; Cardiovascular Research Institute, 550858Loyola University Chicago, Health Sciences Divisions, Maywood, IL, USA.
Fareed J; Program in Health Science, Universidad Católica de Murcia, Spain.

Clin Appl Thromb Hemost ; 28: 10760296221099934, 2022.

Article em En | MEDLINE | ID: mdl-35535398

Assuntos

Enoxaparina; Heparina; Anticoagulantes/farmacologia; Anticoagulantes/uso terapêutico; Enoxaparina/farmacologia; Fator Xa; Heparina/farmacologia; Heparina de Baixo Peso Molecular/farmacologia; Humanos; Protaminas/farmacologia; Proteínas Recombinantes

Palavras-chave

LMWH; UFH; activated clotting time; andexanet alfa; neutralization; thrombelastography

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Heparina / Enoxaparina Limite: Humans Idioma: En Revista: Clin Appl Thromb Hemost Assunto da revista: ANGIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google